---
document_datetime: 2024-09-06 12:25:54
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cholestagel-epar-all-authorised-presentations_en.pdf
document_name: cholestagel-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7138673
conversion_datetime: 2025-12-17 14:11:56.376621
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number                       | Invented name           | Strength      | Pharmaceutical Form                   | Route of Administration   | Packaging                                        | Package size            |
|---------------------------------|-------------------------|---------------|---------------------------------------|---------------------------|--------------------------------------------------|-------------------------|
| EU/1/03/268/003 EU/1/03/268/004 | Cholestagel Cholestagel | 625 mg 625 mg | Film-coated tablet Film-coated tablet | Oral use Oral use         | bottle (HDPE) bottle (HDPE) without outer carton | 180 tablets 180 tablets |